DK244378A - Gelatinekapsel til vedvarende frigoerelse af et farmaceutisk middel - Google Patents

Gelatinekapsel til vedvarende frigoerelse af et farmaceutisk middel

Info

Publication number
DK244378A
DK244378A DK244378A DK244378A DK244378A DK 244378 A DK244378 A DK 244378A DK 244378 A DK244378 A DK 244378A DK 244378 A DK244378 A DK 244378A DK 244378 A DK244378 A DK 244378A
Authority
DK
Denmark
Prior art keywords
capsula
gelatine
pharmaceuticals
sustainable release
sustainable
Prior art date
Application number
DK244378A
Other languages
English (en)
Other versions
DK153773B (da
DK153773C (da
Inventor
J Mcainsh
R C Rowe
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of DK244378A publication Critical patent/DK244378A/da
Publication of DK153773B publication Critical patent/DK153773B/da
Application granted granted Critical
Publication of DK153773C publication Critical patent/DK153773C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
DK244378A 1977-06-01 1978-06-01 Fremgangsmaade til fremstillling af et farmaceutisk praeparat til forlaenget frigoerelse af et laegemiddel DK153773C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB23114/77A GB1561204A (en) 1977-06-01 1977-06-01 Sustained release pharmaceutical composition
GB2311477 1977-06-01

Publications (3)

Publication Number Publication Date
DK244378A true DK244378A (da) 1978-12-02
DK153773B DK153773B (da) 1988-09-05
DK153773C DK153773C (da) 1989-01-16

Family

ID=10190344

Family Applications (1)

Application Number Title Priority Date Filing Date
DK244378A DK153773C (da) 1977-06-01 1978-06-01 Fremgangsmaade til fremstillling af et farmaceutisk praeparat til forlaenget frigoerelse af et laegemiddel

Country Status (21)

Country Link
US (1) US4138475A (da)
JP (1) JPS5459315A (da)
AU (1) AU510215B2 (da)
BE (1) BE859288A (da)
CA (1) CA1100040A (da)
CH (1) CH638399A5 (da)
DE (1) DE2740286C2 (da)
DK (1) DK153773C (da)
FR (1) FR2392667A1 (da)
GB (1) GB1561204A (da)
HK (1) HK10381A (da)
IE (1) IE45578B1 (da)
IL (1) IL52914A (da)
IT (1) IT1067667B (da)
KE (1) KE3120A (da)
MY (1) MY8100346A (da)
NL (1) NL7805510A (da)
NO (1) NO773293L (da)
NZ (1) NZ185101A (da)
SE (1) SE7806446L (da)
ZA (1) ZA775370B (da)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248856A (en) * 1979-07-10 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
US4681765A (en) * 1984-09-13 1987-07-21 American Home Products Corporation Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
US4752470A (en) * 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
GB8913889D0 (en) * 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE69014513T2 (de) * 1989-09-21 1995-05-24 American Cyanamid Co System des Typs "einmal täglich" zur gepulsten Minocyclinabgabe.
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
IL96311A (en) * 1989-12-01 1995-05-26 Abbott Lab Medications with delayed release
SE9002017D0 (sv) * 1990-06-06 1990-06-06 Kabivitrum Ab Process for manufacture of matrices
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
BR9206996A (pt) * 1991-12-30 1995-12-05 Fmc Corp Composição adequada para preparar esferóides por esferoidização processo para produzir um material em partículas processo para produzir uma forma de dosagem de sólido esferoidizado em partículas e forma de dosagem sólida
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
SE9301220D0 (sv) * 1993-04-14 1993-04-14 Kabi Pharmacia Ab Manufacturing matrices
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US20060067999A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6306438B1 (en) 1997-07-02 2001-10-23 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
US6544646B2 (en) 2000-04-27 2003-04-08 Verion Inc. Zero order release and temperature-controlled microcapsules and process for the preparation thereof
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US6500454B1 (en) * 2001-10-04 2002-12-31 Eurand Pharmaceuticals Ltd. Timed, sustained release systems for propranolol
EP1485078B1 (en) * 2002-03-15 2012-09-26 Cypress Bioscience, Inc. Milnacipran for the treatment of irritable bowel syndrome
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
US6703044B1 (en) 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) * 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060099259A1 (en) * 2004-11-05 2006-05-11 Grant Heinicke Propranolol formulations
US20060182806A1 (en) * 2004-11-08 2006-08-17 Mintong Guo Extended-release propranolol composition
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070082050A1 (en) * 2005-05-31 2007-04-12 Cherukuri S R Modified release formulations of antihypertensive drugs
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20100215744A1 (en) * 2008-08-06 2010-08-26 Medicis Pharmaceutical Corporation Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical
US9192615B2 (en) * 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) * 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2007102169A1 (en) * 2006-03-08 2007-09-13 Jubilant Organosys Limited Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same
EP1839649A1 (en) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US20080187579A1 (en) * 2007-02-01 2008-08-07 Pavan Bhat Extended-release dosage form
WO2008126098A1 (en) * 2007-04-12 2008-10-23 Jubilant Organosys Limited Extended release pharmaceutical formulation of propranolol hydrochloride
AU2009298139B2 (en) * 2008-10-03 2015-02-19 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
WO2011132008A2 (en) 2010-04-22 2011-10-27 EGIS Gyűgyszergyár Nyilvánosan Múködő Részvény társaság Controlled release pharmaceutical composition
US9566269B2 (en) 2011-01-20 2017-02-14 Bionevia Pharmaceuticals Inc. Modified release compositions of epalrestat or a derivative thereof and methods for using the same
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE644759C (de) * 1932-11-23 1937-05-12 I G Farbenindustrie Akt Ges Verfahren zum UEberziehen von Arzneiformen mit gegen Magensaeure und Magenfermente bestaendigen UEberzuegen
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
GB742007A (en) * 1953-04-01 1955-12-14 Smith Kline & French Internat Improvements in or relating to method of forming coated pharmaceutical pellets
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
NL286829A (da) * 1961-12-29
US3146168A (en) * 1962-04-10 1964-08-25 Fmc Corp Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
US3576759A (en) * 1968-04-12 1971-04-27 Ncr Co Process for en masse production of spherules by desiccation
CA935093A (en) * 1969-07-28 1973-10-09 Eurand S.R.L. Method of preparing granules with controlled release of the active substance contained therein
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
DE2223896A1 (de) * 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US3947592A (en) * 1972-05-22 1976-03-30 Indiana University Foundation Treatment of opiate addiction
DE2301664C3 (de) * 1973-01-13 1979-07-12 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral verabreichbares, Nitroglycerin enthaltendes Arzneimittel
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
GB1425550A (en) * 1973-04-25 1976-02-18 Alza Corp Device for releasing active agent and process for producing the same
ZA742728B (en) * 1973-05-08 1975-04-30 Simes Pharmaceutical composition for the treatment of coronaric ailments
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
JPS50129727A (da) * 1974-04-04 1975-10-14

Also Published As

Publication number Publication date
KE3120A (en) 1981-04-10
US4138475A (en) 1979-02-06
DE2740286C2 (de) 1984-05-03
NZ185101A (en) 1979-03-28
IL52914A (en) 1980-06-30
IT1067667B (it) 1985-03-16
IE45578L (en) 1978-12-01
CA1100040A (en) 1981-04-28
FR2392667B1 (da) 1981-07-31
FR2392667A1 (fr) 1978-12-29
DE2740286A1 (de) 1978-12-07
SE7806446L (sv) 1978-12-02
BE859288A (fr) 1978-03-30
DK153773B (da) 1988-09-05
ZA775370B (en) 1979-01-31
JPS5740804B2 (da) 1982-08-30
NL7805510A (nl) 1978-12-05
GB1561204A (en) 1980-02-13
HK10381A (en) 1981-03-27
DK153773C (da) 1989-01-16
MY8100346A (en) 1981-12-31
IE45578B1 (en) 1982-10-06
NO773293L (no) 1978-12-04
AU510215B2 (en) 1980-06-12
JPS5459315A (en) 1979-05-12
CH638399A5 (de) 1983-09-30
AU2861477A (en) 1979-03-15

Similar Documents

Publication Publication Date Title
DK244378A (da) Gelatinekapsel til vedvarende frigoerelse af et farmaceutisk middel
DK271677A (da) Fremgangsmade til fremstilling af et farmaceutisk indsetningspreparat
DK483176A (da) Fremgangsmade til fremstilling af et kemoterapeutikum
DK151931C (da) Fremgangsmaade til fremstilling af et farmacentisk praeparat i enhedsdosisform
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK538978A (da) Fremgangsmaade til fremstilling af et lokalanaestetisk virksomt praeparat
DK252177A (da) Fremgangsmade til forbedring af et af skrald fremstillet fibermateriale
DK113676A (da) Fremgangsmade til fremstilling af et retardpreparat
DK149751C (da) Analogifremgangsmaade til fremstilling af et salt af et bistetrahydroisoquinolinium-derivat og mellemproduktforbindelsen til udaevelse af fremgangsmaaden
DK143078A (da) Tablettering af mikrokapsler
DK140977A (da) Fremgangsmade til kryogen formgivning af en metalplade
DK454876A (da) Fremgangsmade til fremstilling af en tablet til reguleret medikamentfrigivelse
DK1978A (da) Fremgangsmaade til fremstilling af en lerdue
DK142490C (da) Holder til fastholdelse af en cykel
DK154704C (da) Fremgangsmaade til fremstilling af et sesquiterpenderivat eller salte deraf
DK352578A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK452578A (da) Fremgangsmaade til fremstilling af furanderivater
DK523277A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med protraheret virkning
DK43676A (da) Fremgangsmade til fremstilling af et cytotoksisk middel
DK169378A (da) Fremgangsmaade til fremstilling af en oploesning
DK143173C (da) Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
DK582377A (da) Fremgangsmaade til foroegelse af en given reaktivitet af phosphorpentsaulfid
DK550276A (da) Fremgangsmade til fremstilling af en krystalmodifikation af et natriumsalt
DK105177A (da) Fremgangsmaade til fremstilling af en protozoel biomasse
DK338576A (da) Fremgangsmade til fremstilling af et salt af alfa-methyl-5-benzoyl-2-thiopheneddikesyre

Legal Events

Date Code Title Description
PUP Patent expired